Literature DB >> 24124323

Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.

Nicola de Bortoli1, Irene Martinucci, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Corrado Blandizzi, Santino Marchi.   

Abstract

Several studies indicate a significant degree of overlap between irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). Likewise, both functional heartburn (FH) and IBS are functional digestive disorders that may occur in the same patients. However, data establishing a solid link between FH and IBS are lacking, mainly because the clinical definition of FH has undergone substantial changes over the years. The available literature on the overlap between GERD or FH and IBS highlights considerable heterogeneity in terms of the criteria and diagnostic procedures used to assess heartburn and IBS. In particular, several epidemiological studies included patients with concomitant IBS and GERD without any attempt to distinguish FH (as defined by the Rome III criteria) from GERD via pathophysiological investigations. Independent of these critical issues, there is preliminary evidence supporting a significant degree of FH-IBS overlap. This underscores the need for studies based on updated diagnostic criteria and accurate pathophysiological classifications, particularly to distinguish FH from GERD. This distinction would represent an essential starting point to achieving a better understanding of pathophysiology in the subclasses of patients with GERD and FH and properly assessing the different degrees of overlap between IBS and the subcategories of heartburn.The present review article intends to appraise and critically discuss current evidence supporting a possible concomitance of GERD or FH with IBS in the same patients and to highlight the pathophysiological relationships between these disorders.

Entities:  

Keywords:  Acidity (esophageal); Functional gastrointestinal disorders; Gastroesophageal reflux disease/Gastro-oesophageal reflux disease; Hypersensitivity; Irritable bowel syndrome

Mesh:

Year:  2013        PMID: 24124323      PMCID: PMC3793133          DOI: 10.3748/wjg.v19.i35.5787

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  83 in total

1.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

2.  Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice.

Authors:  François Guillemot; Philippe Ducrotté; Lionel Bueno
Journal:  Gastroenterol Clin Biol       Date:  2005-03

3.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

4.  Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.

Authors:  T K Cheung; K F Lam; W H C Hu; C L K Lam; W M Wong; W M Hui; K C Lai; S K Lam; B C Y Wong
Journal:  Aliment Pharmacol Ther       Date:  2007-05-01       Impact factor: 8.171

Review 5.  Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?

Authors:  K-A Gwee
Journal:  Neurogastroenterol Motil       Date:  2005-06       Impact factor: 3.598

6.  Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity.

Authors:  Enrique Rey; Mónica García-Alonso; Marta Moreno-Ortega; Cristina Almansa; Angel Alvarez-Sanchez; Manuel Díaz-Rubio
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

7.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

8.  Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.

Authors:  Kwang Jae Lee; Heok Chun Kwon; Jae Yeon Cheong; Sung Won Cho
Journal:  Digestion       Date:  2009-03-23       Impact factor: 3.216

Review 9.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

Review 10.  Studying the overlap between IBS and GERD: a systematic review of the literature.

Authors:  Igor Nastaskin; Edgar Mehdikhani; Jeffrey Conklin; Sandy Park; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

View more
  15 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

Review 2.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Functional heartburn.

Authors:  Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

4.  Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.

Authors:  Nicola de Bortoli; Leonardo Frazzoni; Edoardo V Savarino; Marzio Frazzoni; Irene Martinucci; Aleksandra Jania; Salvatore Tolone; Michele Scagliarini; Massimo Bellini; Elisa Marabotto; Manuele Furnari; Giorgia Bodini; Salvatore Russo; Lorenzo Bertani; Veronica Natali; Lorenzo Fuccio; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  Am J Gastroenterol       Date:  2016-09-20       Impact factor: 10.864

5.  Update on Functional Heartburn.

Authors:  Takahisa Yamasaki; Jessica O'Neil; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

Review 6.  Optimal management of constipation associated with irritable bowel syndrome.

Authors:  Manuele Furnari; Nicola de Bortoli; Irene Martinucci; Giorgia Bodini; Matteo Revelli; Elisa Marabotto; Alessandro Moscatelli; Lorenzo Del Nero; Edoardo Savarino; Edoardo G Giannini; Vincenzo Savarino
Journal:  Ther Clin Risk Manag       Date:  2015-05-30       Impact factor: 2.423

Review 7.  Sex and Gender Differences in Gastroesophageal Reflux Disease.

Authors:  Young Sun Kim; Nayoung Kim; Gwang Ha Kim
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

8.  Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus.

Authors:  Midori Fujishiro; Akifumi Kushiyama; Hiroki Yamazaki; Sunao Kaneko; Yuko Koketsu; Takeshi Yamamotoya; Takako Kikuchi; Hideyuki Sakoda; Ryo Suzuki; Takashi Kadowaki
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

9.  Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease.

Authors:  Edoardo Savarino; Patrizia Zentilin; Manuele Furnari; Giorgia Bodini; Elisa Marabotto; Vincenzo Savarino
Journal:  J Neurogastroenterol Motil       Date:  2014-01       Impact factor: 4.924

10.  Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.

Authors:  Nimish Vakil; Anna Niklasson; Hans Denison; Anna Rydén
Journal:  BMC Gastroenterol       Date:  2014-10-10       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.